28 related articles for article (PubMed ID: 32333734)
1. Survival After Cryotherapy Versus Radiotherapy in Low and Intermediate Risk Localized Prostate Cancer.
Li H; Xu Z; Lv Z; Wang M; Liu M
Clin Genitourin Cancer; 2023 Dec; 21(6):679-693. PubMed ID: 37422351
[TBL] [Abstract][Full Text] [Related]
2. The impact of comorbidity on overall survival in elderly nasopharyngeal carcinoma patients: a National Cancer Data Base analysis.
Huang Y; Chen W; Haque W; Verma V; Xing Y; Teh BS; Brian Butler E
Cancer Med; 2018 Apr; 7(4):1093-1101. PubMed ID: 29493889
[TBL] [Abstract][Full Text] [Related]
3. Changes in functional status associated with radiation for prostate cancer in older veterans.
Ursem C; Diaz-Ramirez LG; Boscardin J; Lee S
J Geriatr Oncol; 2021 Jun; 12(5):808-812. PubMed ID: 33388282
[TBL] [Abstract][Full Text] [Related]
4. Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer.
Holmes OE; MacRae R; Cook G; Cross P; Nair V; Marginean H; Pantarotto JR
Clin Transl Radiat Oncol; 2017 Aug; 5():37-41. PubMed ID: 29594215
[TBL] [Abstract][Full Text] [Related]
5. Association between Charlson comorbidity index and survival outcomes in patients with prostate cancer: A meta-analysis.
Cui F; Qiu Y; Xu W; Shan Y; Liu C; Zou C; Fan Y
Heliyon; 2024 Feb; 10(4):e25728. PubMed ID: 38390166
[TBL] [Abstract][Full Text] [Related]
6. How to model temporal changes in comorbidity for cancer patients using prospective cohort data.
Lindhagen L; Van Hemelrijck M; Robinson D; Stattin P; Garmo H
BMC Med Inform Decis Mak; 2015 Nov; 15():96. PubMed ID: 26582418
[TBL] [Abstract][Full Text] [Related]
7. Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer.
Yegya-Raman N; Kegelman TP; Ho Lee S; Kallan MJ; Kim KN; Natarajan J; Deek MP; Zou W; O'Reilly SE; Zhang Z; Levin W; Cengel K; Kao G; Cohen RB; Sun LL; Langer CJ; Aggarwal C; Singh AP; O'Quinn R; Ky B; Apte A; Deasy J; Xiao Y; Berman AT; Jabbour SK; Feigenberg SJ
Clin Transl Radiat Oncol; 2023 Mar; 39():100581. PubMed ID: 36691564
[TBL] [Abstract][Full Text] [Related]
8. Surgical and oncological results after rectal resections with or without previous treatment for prostate cancer.
Tomminen T; Huhtala H; Kotaluoto S; Veitonmäki T; Wirta EV; Hyöty M
Front Surg; 2024; 11():1298865. PubMed ID: 38362461
[TBL] [Abstract][Full Text] [Related]
9. Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbidities.
AlAshqar A; Ghazarian M; Webster EM; Upadhyay A; Azodi M; Schwartz PE; Ratner E; Altwerger G
Gynecol Oncol Rep; 2023 Oct; 49():101240. PubMed ID: 37636496
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study.
Westerberg M; Irenaeus S; Garmo H; Stattin P; Gedeborg R
PLoS One; 2024; 19(1):e0296804. PubMed ID: 38236934
[TBL] [Abstract][Full Text] [Related]
11. Prospective Study of Incidence and Impact of Comorbidities on Breast Cancer Survival from India.
Wadasadawala T; Datta D; Puchali N; Rane P; Sen S; Mohanty S; Gupta S; Sarin R; Parmar V
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3805-3814. PubMed ID: 38019238
[TBL] [Abstract][Full Text] [Related]
12. Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry.
Orabi H; Howard L; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Klaassen Z; Janes JL; Freedland SJ; Polascik TJ
Eur Urol Open Sci; 2022 Mar; 37():106-112. PubMed ID: 35243395
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a Clinical Trial-Derived Survival Model in Patients With Metastatic Castration-Resistant Prostate Cancer.
Coquet J; Bievre N; Billaut V; Seneviratne M; Magnani CJ; Bozkurt S; Brooks JD; Hernandez-Boussard T
JAMA Netw Open; 2021 Jan; 4(1):e2031730. PubMed ID: 33481032
[TBL] [Abstract][Full Text] [Related]
14. Hypogonadism and its treatment among prostate cancer survivors.
Choi EJ; Xu P; El-Khatib FM; Huynh LM; Yafi FA
Int J Impot Res; 2021 May; 33(4):480-487. PubMed ID: 33311575
[TBL] [Abstract][Full Text] [Related]
15. Charlson Comorbidity score influence on prostate cancer survival and radiation-related toxicity.
Ghanem AI; Khalil RM; Khedr GA; Tang A; Elsaid AA; Chetty IJ; Movsas B; Elshaikh MA
Can J Urol; 2020 Apr; 27(2):10154-10161. PubMed ID: 32333734
[TBL] [Abstract][Full Text] [Related]
16. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy.
Dong Y; Ruth KJ; Churilla TM; Viterbo R; Sobczak ML; Smaldone MC; Chen DY; Uzzo RG; Hallman MH; Horwitz EM
Can J Urol; 2017 Feb; 24(1):8656-8662. PubMed ID: 28263132
[TBL] [Abstract][Full Text] [Related]
17. Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial.
Michalski JM; Moughan J; Purdy J; Bosch W; Bruner DW; Bahary JP; Lau H; Duclos M; Parliament M; Morton G; Hamstra D; Seider M; Lock MI; Patel M; Gay H; Vigneault E; Winter K; Sandler H
JAMA Oncol; 2018 Jun; 4(6):e180039. PubMed ID: 29543933
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without Chemotherapy.
Caparrotti F; O'Sullivan B; Bratman SV; Ringash J; Lu L; Bayley A; Cho J; Giuliani M; Hope A; Kim J; Waldron J; Hansen A; Goldstein D; Perez-Ordonez B; Weinreb I; Tong L; Song Y; Xu W; Huang SH
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):858-867. PubMed ID: 28258893
[TBL] [Abstract][Full Text] [Related]
19. Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer.
Kupelian PA; Mohan DS; Lyons J; Klein EA; Reddy CA
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):567-74. PubMed ID: 10701735
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
